Are You Currently Being Treated for a Relapsing Remitting Form of Multiple Sclerosis?
A voluntary research study is currently being conducted to evaluate different medications to treat relapsing remitting forms of multiple sclerosis (MS).
Qualified Participants Must:
Be between 18 and 65 years of age
Have been diagnosed with a relapsing remitting form of MS
Be naïve to treatment or have been treated with no more than one class of disease modifying therapy (DMT)
Qualified Participants May Receive:
Study-related exams and study medication at no cost.